segment
jejunum
day
old
piglet
surgic
ligat
inocul
transmiss
gastroenter
viru
tgev
hour
later
segment
fix
histolog
suspens
prepar
plaqu
assay
swine
testi
st
cell
cultur
determin
yield
viru
virul
purdu
strain
tgev
use
villou
atrophi
seen
tgev
antigen
demonstr
immunohistochem
villou
enterocyt
miller
strain
viru
produc
less
extens
lesion
segment
sinc
titrat
plaqu
assay
use
subsequ
yield
reduct
assay
determin
antivir
activ
interferon
intestin
segment
inocul
simultan
either
unit
natur
porcin
interferona
unit
recombin
human
tgev
reduct
viru
yield
although
cytokin
exert
antivir
effect
st
ceil
treat
similar
way
howev
viru
yield
significantli
reduc
intestin
segment
piglet
treat
parenter
synthet
interferon
induc
polyinosin
polycytidyl
acid
hour
challeng
segment
tgev
also
trend
antivir
effect
interferon
induct
challeng
augment
inclus
interferon
viru
inoculum
conclud
interferon
would
ineffect
therapeut
tgev
although
might
use
prophylact
transmiss
gastroenter
viru
tgev
enter
coronaviru
associ
high
mortal
prewean
pig
follow
oral
exposur
viral
replic
occur
primarili
matur
villou
epithelium
jejunum
ileum
hooper
haelterman
saif
heckert
lysi
infect
cell
lead
villou
atrophi
crypt
hyperplasia
diarrhoea
result
maldigest
malabsorpt
loss
electrolyt
protein
damag
epithelium
lead
dehydr
nutrit
defici
electrolyt
imbal
butler
et
al
antivir
activ
associ
tgev
infect
first
describ
intestin
wash
neonat
pig
pensaert
et
al
activ
later
shown
due
alpha
interferon
ifna
la
bonnardir
laud
sourc
interferon
unknown
thought
gut
associ
lymphoid
tissu
recent
shown
ifnot
induct
depend
tgev
transmembran
protein
laud
laud
et
al
ifnt
produc
lamina
propria
lymphocyt
expos
tgev
naidoo
derbyshir
role
endogen
ifn
produc
earli
cours
infect
tgev
current
understood
virtu
antivir
activ
may
restrict
cycl
viral
replic
intestin
epithelium
major
object
present
studi
investig
possibl
ligat
intestin
segment
model
exogen
ifna
could
inject
intestin
segment
concurr
infect
viru
clearli
establish
ifnt
exert
antivir
role
tgev
cell
cultur
intestin
explant
pretreat
ifn
challeng
viru
derbyshir
weingartl
derbyshir
present
studi
cell
cultur
treat
simultan
ifno
tgev
sinc
antivir
effect
demonstr
similar
experi
conduct
ligat
intestin
segment
model
sinc
possibl
produc
porcin
po
ifnot
vitro
concentr
compar
detect
vivo
la
bonnardir
laud
high
concentr
human
recombin
ifna
use
experi
treatment
newborn
piglet
synthet
ifn
induc
polyinosin
polycytidyl
acid
poli
c
complex
polyllysin
carboxymethylcellulos
poli
iclc
oral
exposur
virul
tgev
result
delay
onset
clinic
sign
loewen
derbyshir
time
poli
iclc
administr
relat
exposur
viru
like
transient
protect
effect
due
activ
natur
killer
cell
activ
treat
piglet
lesnick
derbyshir
present
studi
util
ligat
intestin
segment
model
observ
antivir
effect
poli
iclc
newborn
piglet
initi
experi
descib
paper
relat
develop
ligat
intestin
segment
model
tgev
particularli
select
suitabl
strain
viru
appropri
challeng
dose
give
consist
viru
yield
techniqu
use
prefer
whole
anim
sinc
allow
comparison
differ
treatment
within
one
individu
greatli
reduc
number
anim
requir
studi
method
wide
use
studi
enter
bacteri
gyle
barnum
viral
carpio
et
al
kirsten
et
al
deregt
et
al
infect
studi
tgev
sow
specificpathogen
free
herd
commerci
swine
farrow
isol
herd
determin
tgev
porcin
respiratori
coronaviru
neg
viru
neutral
serolog
piglet
given
mg
iron
dextran
ironol
sanofi
anim
health
victoriavil
quebec
day
age
day
age
piglet
remov
sow
prepar
experiment
surgeri
procedur
carri
canadian
council
anim
care
guidelin
virul
purdu
strain
tgev
propag
collect
infect
pig
method
ristic
et
al
miller
strain
tgev
obtain
dr
l
saif
ohio
state
univers
propag
assay
use
contin
swine
testi
st
cell
line
mcclurkin
norman
viru
plaqu
purifi
three
time
pass
seven
time
st
cell
welch
saif
assay
plaqu
format
st
cell
monolay
cultur
grown
well
plate
inocul
ml
viru
serial
dilut
eagl
minimum
essenti
medium
emem
adsorpt
one
hour
inoculum
remov
well
overlay
ml
agaros
emem
neonat
calf
serum
nnc
plate
fix
phosphat
buffer
formalin
stain
crystal
violet
hour
natur
porcin
leucocyt
ifn
polfnot
produc
describ
weingartl
derbyshir
venou
blood
wean
pig
collect
sodium
heparin
mix
equal
volum
hank
balanc
salt
solut
hbss
leucocyt
separ
centrifug
ficollpaqu
pharmacia
lkb
biotechnolog
inc
piscataway
new
jersey
wash
hbss
cellsml
suspend
medium
contain
foetal
bovin
serum
hepe
buffer
incub
shake
rpm
hour
leucocyt
cultur
inocul
haemagglutin
unit
newcastl
diseas
viru
la
sota
strain
twentyfour
hour
postinfect
leucocyt
pellet
centrifug
supernat
treat
ml
mm
dithiothreitol
sigma
chemic
st
loui
missouri
per
millilitr
viru
remov
ultracentrifug
g
min
supernat
store
c
human
recombin
interferon
hu
rec
obtain
commerci
sourc
roferon
hoffman
la
roch
antivir
activ
determin
describ
system
intern
unit
equival
laboratori
unit
interferon
assay
plaqu
reduct
sampl
assay
serial
dilut
emem
contain
nnc
ml
appli
well
well
pate
contain
monolay
madindarbi
bovin
kidney
cell
hour
sampl
remov
plate
treat
plaqu
form
unit
pfu
vesicular
stomat
viru
indiana
strain
follow
min
adsorpt
inoculum
remov
well
overlay
ml
gum
tragacanth
sigma
chemic
emem
nnc
fortyeight
hour
post
infect
cell
fix
phosphatebuff
formalin
stain
crystal
violet
ifn
titr
determin
reciproc
highest
dilut
result
reduct
number
plaqu
polyinosin
polycytidyl
acid
complex
polyllysin
carboxymethylcellulos
poli
iclc
prepar
describ
levi
et
al
modifi
loewen
derbyshir
polyinosin
polycytidyl
acid
poli
c
sigma
chemic
reanneal
heat
min
ad
mixtur
contain
equal
volum
polyllysin
mgml
sigma
chemic
normal
salin
carboxymethyl
cellulos
sigma
chemic
yield
final
concentr
mgml
poli
c
piglet
inocul
intraven
mgkg
poli
c
protocol
previous
describ
derbyshir
four
day
old
monolay
cultur
st
ceil
well
plate
treat
hour
hu
rec
dilut
emem
contain
nnc
wash
phosphat
buffer
salin
pb
cell
treat
pfuwel
miller
tgev
repres
multipl
infect
follow
adsorpt
hour
inoculum
remov
replac
emem
nnc
without
ifn
supernat
collect
viru
assay
hour
later
piglet
remov
sow
depriv
food
water
hour
prior
surgeri
anaesthesia
induc
maintain
halothan
fluothan
ayerst
laboratori
montreal
use
bain
circuit
midlin
laparotomi
perform
five
cm
long
segment
midjejunum
isol
ligat
cm
interven
segment
cm
segment
inject
intralumen
total
ml
volum
viru
one
inject
experi
ifn
second
inject
dilut
pb
contain
kallikrein
unit
aprotinin
sigma
chemic
proteas
inhibitor
penicillin
unitsml
streptomycin
mg
ml
gentamicin
mgml
control
inocul
consist
pb
diluent
except
experi
involv
natur
po
ifnot
case
mockinduc
leucocyt
supernat
use
control
inoculum
incis
close
layer
anim
allow
recov
anaesthesia
flunixin
meglumin
mgkg
banamin
schefingplough
administ
maintain
analgesia
postop
water
provid
piglet
remain
alert
activ
clinic
evid
dehydr
eighteen
hour
infect
anim
anaesthetis
intestin
sampl
collect
histolog
examin
immunostain
place
immedi
phosphat
buffer
formalin
viru
assay
ligat
segment
remov
place
ml
emem
contain
antibiot
frozen
c
thaw
intestin
content
mucosa
scrape
media
vortex
refrozen
sampl
thaw
mix
clarifi
centrifug
g
min
store
assay
piglet
euthan
barbitur
overdos
sampl
collect
euthansol
scheringplough
intestin
section
fix
phosphat
buffer
formalin
hour
transfer
ethanol
prior
embed
paraffin
slide
stain
use
streptavidin
immunoperoxidas
techniqu
dimens
laboratori
mississauga
ontario
briefli
dewax
rehydr
section
treat
proteas
rain
endogen
peroxidas
activ
block
hydrogen
peroxid
rain
normal
rabbit
block
serum
appli
min
without
rins
mous
antitgev
monoclon
antibodi
nonspecif
mous
monoclon
antibodi
control
appli
rain
rins
biotinyl
rabbit
antimous
serum
appli
rain
bind
detect
use
streptavidinperoxidas
conjug
min
follow
chromogen
solut
contain
aminoethylcarbazol
hydrogen
peroxid
slide
counterstain
briefli
haematoxylin
singl
piglet
use
preliminari
experi
ligat
segment
inocul
dilut
virul
pigpassag
purdu
strain
tgev
rang
pb
control
inoculum
histolog
chang
consist
natur
occur
tgev
infect
includ
cytoplasm
vacuol
enteroeyt
enlarg
hecrosi
villou
atrophi
dilut
length
villi
reduc
approxim
comparison
control
segment
histolog
abnorm
seen
extent
chang
occur
dose
depend
somewhat
variabl
along
length
individu
segment
immunohistochemistri
reveal
intens
specif
stain
tgev
antigen
villou
enterocyt
also
lumen
debri
fig
nonspecif
stain
occur
primarili
musculari
mucosa
around
blood
vessel
erythrocyt
nonspecif
stain
readili
distinguish
viral
antigen
basi
locat
colour
intens
viru
isol
infect
control
segment
miller
strain
tgev
inocul
concentr
two
ligat
segment
three
piglet
one
segment
piglet
use
histolog
one
viru
isol
three
controlinocul
segment
piglet
viru
produc
less
mark
histolog
chang
purdu
strain
specif
immunostain
tgev
antigen
seen
villou
enterocyt
fig
chang
seen
control
segment
viru
isol
yield
viru
obtain
infect
segment
shown
tabl
data
tabl
indic
st
cell
cultur
miller
tgev
sensit
treatment
hu
rec
viru
yield
reduct
evid
dose
ifn
use
treatment
regimen
harvest
experi
tabl
unit
ofpo
ifna
inocul
four
ligat
segment
three
piglet
number
loop
receiv
control
inoculum
piglet
inoculum
two
ifn
control
segment
contain
pfu
miller
tgev
pfu
two
segment
addit
control
segment
viru
recov
uninfect
control
segment
shown
tabl
signific
reduct
viru
yield
evid
student
ttest
intestin
segment
treat
simultan
polfna
tgev
higher
concentr
hu
rec
viru
two
piglet
inocul
poli
iclc
two
inocul
control
solut
contain
polyllysin
carboxymethylcellulos
lack
poli
c
poli
iclc
treatment
result
appear
circul
ifn
hour
posttreat
tabl
level
greatli
decreas
hour
posttreat
control
solut
induc
circul
ifn
hour
poli
iclc
treatment
also
associ
transient
leucopaenia
involv
segment
neutrophil
lymphocyt
hour
persist
segment
neutrophil
hour
evid
system
ifn
respons
inocul
intestin
segment
tgev
may
due
local
natur
infect
rel
avirul
miller
strain
may
indic
strain
poor
induc
ifn
two
poli
iclc
treat
piglet
two
control
piglet
four
ligat
segment
inocul
unit
hu
ifn
four
tabl
signific
reduct
viru
yield
student
ttest
p
intestin
segment
piglet
treat
poli
iclc
also
trend
effect
poli
iclc
treatment
augment
subsequ
intralumen
ifn
treatment
though
signific
p
earlier
experi
signific
reduct
viru
yield
ifn
treat
segment
control
piglet
previou
experiment
describ
use
isol
intestin
loop
studi
tgev
pathogenesi
rel
larg
length
small
bowel
exterior
pensaert
et
al
techniqu
ideal
studi
sequenti
event
occur
tgev
infect
thought
suitabl
purpos
object
compar
effect
variou
treatment
length
small
bowel
day
old
convent
piglet
approxim
two
metr
studi
fourteen
cm
segment
use
although
segment
found
satisfactori
maximum
anim
age
miller
strain
tgev
select
use
yield
reduct
assay
could
readili
titrat
cell
cultur
contrast
virul
purdu
viru
less
virul
purdu
strain
miller
strain
capabl
replic
intestin
segment
contrast
vaccin
strain
tgev
evalu
preliminari
experi
result
shown
antigen
nucleotid
sequenc
data
establish
close
relationship
porcin
human
alpha
interferon
la
bonnardir
et
al
lefevr
la
bonnardir
lefevr
et
al
weingartl
human
interferon
shown
antivir
activ
nonhuman
cell
gresser
et
al
human
interferon
also
shown
activ
felin
infecti
periton
viru
coronaviru
close
relat
tgev
weiss
oostramram
oral
treatment
human
ifn
report
decreas
rotaviru
shed
pig
lecc
et
al
previou
report
describ
reduct
tgev
yield
follow
treatment
porcin
bovin
ifn
cell
intestin
explant
cultur
maclachlan
anderson
derbyshir
weingartl
derbyshir
particular
interest
present
studi
demonstr
posttreat
st
cell
cultur
viru
inocul
low
multipl
viru
would
result
decreas
subsequ
viru
yield
intestin
segment
experi
howev
simultan
treatment
ofenterocyt
po
ifnot
hu
rec
tgev
caus
decreas
viru
yield
possibl
kinet
viral
replic
andor
kinet
ifn
system
differ
enterocyt
rel
st
cell
cultur
viral
replic
well
underway
time
effect
antivir
state
induc
also
possibl
ifn
inoculum
degrad
intestin
proteas
despit
inclus
proteas
inhibitor
inoculum
effect
ofpoli
iclc
circul
ifn
level
leucocyt
valu
consist
previous
describ
derbyshir
loewen
derbyshir
present
studi
demonstr
addit
activ
natur
killer
cell
previous
describ
lesnick
derbyshir
poli
iclc
treatment
result
decreas
tgev
yield
enterocyt
may
factor
delay
onset
clinic
sign
associ
poli
iclc
treatment
loewen
derbyshir
certain
whether
reduc
viru
yield
intestin
segment
polyiclc
treat
piglet
result
direct
antivir
effect
induc
ifn
enterocyt
lysi
enterocyt
earli
infect
nk
cell
activ
induc
ifn
latter
mechan
seem
less
like
sinc
intestin
segment
infect
tgev
well
nk
activ
would
peak
lesnick
derbyshir
direct
effect
induct
antivir
state
enterocyt
seem
like
shown
oligoadenyl
synthetas
induc
tgev
infect
also
produc
ifn
treat
porcin
cell
cultur
bosworth
et
al
bosworth
maclachlan
whether
system
involv
antivir
state
tgev
remain
determin
fact
simultan
ifn
treatment
decreas
viru
yield
intestin
segment
may
preclud
use
ifn
treatment
tgev
infect
howev
reduct
viru
yield
follow
administr
ifn
induc
suggest
ifn
may
use
prophylact
